首页> Blood> High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.

导出 LinkOut

翻译打印收藏纠错

第一作者： Joan,Bladé

第一单位： Hematology Department, Hospital Clínic, IDIBAPS, Villarroel 170, 08036 Barcelona, Spain. jblade@clinic.ub.es

作者： Joan,Bladé ^[1] ; Laura,Rosiñol ; Ana,Sureda ; Josep M,Ribera ; Joaquín,Díaz-Mediavilla ; José,García-Laraña ; M Victoria,Mateos ; Luis,Palomera ; Javier,Fernández-Calvo ; Josep M,Martí ; Pilar,Giraldo ; Félix,Carbonell ; Manel,Callís ; Jesús,Trujillo ; Santiago,Gardella ; M Jesús,Moro ; Abelardo,Barez ; Alfons,Soler ; Llorenç,Font ; Montserrat,Fontanillas ; Jesús,San Miguel ; Programa para el Estudio de la Terapéutica en Hemopatía Maligna (PETHEMA)

作者单位： Hematology Department, Hospital Clínic, IDIBAPS, Villarroel 170, 08036 Barcelona, Spain. jblade@clinic.ub.es ^[1]